Star Portfolios
EMERALD INVESTMENTS LIMITED
Institution · data to Jun 2024
Disclosed value
₹1,077 Cr
Jun 2024 closes
At current prices
…
Current holdings
2
Tracked since
Dec 2019
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Jun 2024)
0.00pp₹1,012 Cr
0.00pp₹65 Cr
| Company | Holding | QoQ | Value |
|---|---|---|---|
| ERIS Lifesciences Ltd | 7.27% | flat | ₹1,012 Cr |
| Krishna Institute of Medical Sciences Ltd | 1.96% | flat | ₹65 Cr |
Portfolio Summary
Jun 2024As of Jun 2024, EMERALD INVESTMENTS LIMITED — an institution tracked through public shareholding filings — disclosed 2 holdings in Indian listed companies worth ₹1,077 crore. The same holdings-at-filing-value basis put it at ₹898 crore in Mar 2024 (+19.9%). Solomo carries these filings back to Dec 2019.
Largest disclosed positions in Jun 2024: ERIS Lifesciences Ltd (ERIS — 7.27% of the company, ₹1,012 crore); Krishna Institute of Medical Sciences Ltd (KIMS — 1.96% of the company, ₹65 crore).
| Quarter | Disclosed value | Change |
|---|---|---|
| Jun 2024 | ₹1,077 Cr | +19.9% |
| Mar 2024 | ₹898 Cr | −10.2% |
| Dec 2023 | ₹1,001 Cr | +3.6% |
| Sep 2023 | ₹966 Cr | +24.3% |
| Jun 2023 | ₹777 Cr | +22.5% |
| Mar 2023 | ₹634 Cr | −11.5% |
| Dec 2022 | ₹716 Cr | −8.3% |
| Sep 2022 | ₹781 Cr | +15.9% |
All star portfolios 1 further position appears in earlier filings but not in Jun 2024.Quarterly shareholding filings (BSE/NSE); only stakes above the 1% disclosure threshold are public. Not investment advice.